Correlation Between Lumos Pharma and MAIA Biotechnology
Can any of the company-specific risk be diversified away by investing in both Lumos Pharma and MAIA Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lumos Pharma and MAIA Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lumos Pharma and MAIA Biotechnology, you can compare the effects of market volatilities on Lumos Pharma and MAIA Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lumos Pharma with a short position of MAIA Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lumos Pharma and MAIA Biotechnology.
Diversification Opportunities for Lumos Pharma and MAIA Biotechnology
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Lumos and MAIA is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Lumos Pharma and MAIA Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAIA Biotechnology and Lumos Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lumos Pharma are associated (or correlated) with MAIA Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAIA Biotechnology has no effect on the direction of Lumos Pharma i.e., Lumos Pharma and MAIA Biotechnology go up and down completely randomly.
Pair Corralation between Lumos Pharma and MAIA Biotechnology
Given the investment horizon of 90 days Lumos Pharma is expected to generate 0.16 times more return on investment than MAIA Biotechnology. However, Lumos Pharma is 6.1 times less risky than MAIA Biotechnology. It trades about -0.16 of its potential returns per unit of risk. MAIA Biotechnology is currently generating about -0.11 per unit of risk. If you would invest 445.00 in Lumos Pharma on August 28, 2024 and sell it today you would lose (15.00) from holding Lumos Pharma or give up 3.37% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lumos Pharma vs. MAIA Biotechnology
Performance |
| Timeline |
| Lumos Pharma |
| MAIA Biotechnology |
Lumos Pharma and MAIA Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lumos Pharma and MAIA Biotechnology
The main advantage of trading using opposite Lumos Pharma and MAIA Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lumos Pharma position performs unexpectedly, MAIA Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAIA Biotechnology will offset losses from the drop in MAIA Biotechnology's long position.| Lumos Pharma vs. Shattuck Labs | Lumos Pharma vs. Eliem Therapeutics | Lumos Pharma vs. Champions Oncology | Lumos Pharma vs. Century Therapeutics |
| MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |